Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TENOFOVIR DISOPROXIL Cause Hyperkalaemia? 39 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Hyperkalaemia have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 0.1% of all adverse event reports for TENOFOVIR DISOPROXIL.

39
Reports of Hyperkalaemia with TENOFOVIR DISOPROXIL
0.1%
of all TENOFOVIR DISOPROXIL reports
3
Deaths
23
Hospitalizations

How Dangerous Is Hyperkalaemia From TENOFOVIR DISOPROXIL?

Of the 39 reports, 3 (7.7%) resulted in death, 23 (59.0%) required hospitalization.

Is Hyperkalaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?

Bone density decreased (10,586) Renal injury (9,255) Skeletal injury (8,320) Chronic kidney disease (7,230) Osteonecrosis (7,182) Bone loss (7,040) Multiple fractures (6,793) Renal failure (6,388) Osteoporosis (5,302) Tooth loss (4,483)

What Other Drugs Cause Hyperkalaemia?

METFORMIN (2,565) SPIRONOLACTONE (2,518) FUROSEMIDE (2,035) RAMIPRIL (1,383) SACUBITRIL\VALSARTAN (1,192) SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036) LISINOPRIL (948) POTASSIUM (944) BISOPROLOL (850) TACROLIMUS (713)

Which TENOFOVIR DISOPROXIL Alternatives Have Lower Hyperkalaemia Risk?

TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV TENOFOVIR DISOPROXIL vs TEPOTINIB TENOFOVIR DISOPROXIL vs TEPROTUMUMAB TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW TENOFOVIR DISOPROXIL vs TERAZOSIN

Related Pages

TENOFOVIR DISOPROXIL Full Profile All Hyperkalaemia Reports All Drugs Causing Hyperkalaemia TENOFOVIR DISOPROXIL Demographics